1.
J Law Med
; 29(1): 208-223, 2022 Mar.
Artículo
en Inglés
| MEDLINE
| ID: mdl-35362289
RESUMEN
Biosimilar medicines have the potential to increase medicine access and bring cost savings to consumers, but uptake has been slow for a range of reasons. This article analyses one such reason, namely the potential for competitors' promotional materials to use certain terms with technical meanings, such as "interchangeable" and "substitution", in a misleading way. Against the backdrop of a flawed co-regulatory system for pharmaceutical marketing, the article identifies a need for clear regulatory statements about appropriate uses of such terms in pharmaceutical marketing and promotion.
Asunto(s)
Biosimilares Farmacéuticos , Mercadotecnía , Boca , Plásticos
2.
Med J Aust
; 215(9): 435, 2021 11 01.
Artículo
en Inglés
| MEDLINE
| ID: mdl-34622453